Ruud P.m. Dings

Univ Of Arkansas For Med Scis

$2,732,578

Attributed

$2,732,578

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $448K · FY2017–25

$500K$375K$250K$125K$0

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$2,732,578 · 2

By mechanism

R01$1,891,918 · 1

P20$840,660 · 1

Top collaborators

No co-investigators on record.

Most similar at Univ Of Arkansas For Med Scis

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Malignant Neoplasms”

Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Leonard Freedmand · Leidos Biomedical Research, Inc.$108,968,336
Beverly Hayes · Leidos Biomedical Research, Inc.$98,336,166
Martha Hering · Westat, Inc.$57,098,843

Research focus

Malignant NeoplasmsTumor ProgressionAntibioticsMelanomaTumor MicroenvironmentGut MicrobiotaLeukocytesTumorResponseTreatment EfficacyEndothelial CellsTumor ImmunityAffectCancer PatientImmuneIntercellular Adhesion Molecule 1ExtravasationCell Adhesion MoleculesDysbiosisEndotheliumFlow CytometryDorsalImmunosuppressionEffector T Cell